(Q28217820)
Statements
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women (English)
0 references
1 July 2007
0 references
25
0 references
19
0 references
2798-803
0 references